№ lp_2_3_44067
File format: docx
Character count: 54324
File size: 423 KB
Detailed protocol for the examination and reporting of lung resection specimens in oncology, specifying tumor types, procedures, and reporting requirements for accreditation.
Version:
5.1.0.0
Protocol Posting Date:
September 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
June 2026
Note:
The changes included in this current protocol version affect accreditation requirements. The new deadline for implementing this protocol version is reflected in the above accreditation date.
Resection:
Includes pneumonectomy, lobectomy, segmentectomy, and wedge resection
Carcinoma:
Includes non-small cell carcinoma, small cell carcinoma, and carcinoid tumor of the lung
Year:
2025
Region / City:
Global
Theme:
Medical Protocol, Oncology
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Frank Schneider, MD, Kirtee Raparia, MD, FCAP
Target Audience:
Medical professionals in pathology and oncology
Period of Validity:
2025-2026
Approval Date:
September 2025
Modification Date:
September 2025
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / city:
Australia
Topic:
Oncology / Pharmaceutical
Document Type:
Submission
Agency:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
AstraZeneca Pty Ltd
Target Audience:
Medical professionals, regulatory authorities
Validity Period:
2021-2026
Approval Date:
20 April 2021
Modification Date:
Not specified
Year:
2023
Region / City:
Australia
Topic:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Resubmission
Organization:
AstraZeneca Pty Ltd
Author:
Not specified
Target Audience:
Medical Practitioners
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Context:
A pharmaceutical resubmission document outlining the use of osimertinib as a first-line treatment for locally advanced or metastatic EGFRm non-small cell lung cancer (NSCLC) in Australia, including previous PBAC considerations and clinical trial data.
Year:
2023
Region / city:
Australia
Theme:
Oncology, Pharmacology
Document type:
Pharmaceutical submission
Institution:
ELI LILLY AUSTRALIA PTY LTD
Author:
Not specified
Target audience:
Medical professionals, health policy makers
Effective period:
Not specified
Approval date:
3 July 2023
Amendment date:
Not specified
Version:
5.0.0.0
Protocol Posting Date:
December 2023
CAP Laboratory Accreditation Program Protocol Required Use Date:
September 2024
Authors:
Dhanpat Jain, MD; William V. Chopp, MD; Rondell P. Graham, MBBS
Accreditation Requirements:
Core data elements required for clinical care and accreditation purposes. Optional data elements for reporting as determined by local standards.
Procedure:
Resection, biopsy, excision biopsy
Tumor Type:
Well-differentiated neuroendocrine tumor
Year:
2020
Region / City:
Not specified
Topic:
Neuroendocrine Tumors, Pathology, Cancer Accreditation
Document Type:
Protocol
Organization / Institution:
College of American Pathologists (CAP)
Author:
Chanjuan Shi, MD, PhD; Volkan Adsay, MD; Emily K. Bergsland, MD; Jordan Berlin, MD; Philip A. Branton, MD; Patrick L. Fitzgibbons, MD; Wendy L. Frankel, MD; Sanjay Kakar, MD; Veronica Klepeis, MD, PhD; David S. Klimstra, MD; Joseph T. Lewis, MD; Laura H. Tang, MD; Mary K Washington, MD, PhD; Eugene Woltering, MD
Target Audience:
Pathologists, Oncology Professionals, Medical Institutions
Period of Validity:
Effective until November 2020
Approval Date:
February 2020
Date of Changes:
Not specified
Year:
2023
Region / City:
Global
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP
Authors:
Dhanpat Jain, MD; William V. Chopp, MD; Rondell P. Graham, MBBS
Target Audience:
Pathologists, Oncology professionals
Effective Period:
September 2024
Approval Date:
December 2023
Revision Date:
December 2023
Version:
2.0.0.1
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
September 2024
Year:
2024
Region / city:
Duodenum and Ampulla of Vater
Topic:
Neuroendocrine tumors
Document type:
Medical Protocol
Organization / institution:
CAP (College of American Pathologists)
Authors:
Dhanpat Jain, MD; William V. Chopp, MD; Rondell P. Graham, MBBS
Target audience:
Pathologists, Oncology Specialists, Medical Institutions
Effective period:
From June 2024
Approval date:
June 2024
Date of amendments:
Version 2.0.0.1 (June 2024)
Version:
4.4.0.0
Protocol Posting Date:
June 2021
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2022
Authors:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Note:
Accreditation Requirements
Year:
2021
Region / City:
Global
Theme:
Oncology, Breast Cancer
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Medical professionals, pathologists
Period of Validity:
From March 2022
Date of Approval:
June 2021
Date of Changes:
June 2021
Year:
2024
Region / City:
Not specified
Subject:
Pathology, Oncology
Document Type:
Protocol
Organization / Institution:
CAP (College of American Pathologists)
Author:
Uma G. Krishnamurti, MD, PhD; Kimberly H. Allison, MD; Patrick L. Fitzgibbons, MD, FCAP; James L. Connolly, MD
Target Audience:
Pathologists, Medical Institutions
Period of Validity:
March 2025
Approval Date:
Not specified
Date of Last Change:
June 2024
Year:
2019
Region / city:
Not specified
Theme:
Oncology
Document type:
Clinical Protocol
Authors:
Erin Rudzinski, MD; Bruce Pawel, MD; Armita Bahrami, MD; M. John Hicks, MD
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
February 2019
Version:
4.2.1.0
Protocol Posting Date:
June 2025
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2026
Year:
2025
Region / City:
Not specified
Subject:
Renal cell carcinoma, nephrectomy, tumor classification
Document Type:
Protocol
Institution:
CAP (College of American Pathologists)
Author:
Paari Murugan, MD, FCAP*, Robert W. Allan, MD, FCAP*, Lara R. Harik, MD, FCAP*
Target Audience:
Pathologists, medical professionals involved in cancer diagnostics
Effective Period:
March 2026 onward
Approval Date:
June 2025
Revision Date:
Not specified
Year:
2016
Region / City:
Orlando, FL
Theme:
Biomechanics, Orthopaedics
Document Type:
Conference Paper
Organization / Institution:
Orthopaedic Research Society
Authors:
Sueyoshi T, Small SR, Elliot JB, Gibbs GE, Seale RB, Berend ME, Ritter MA
Target Audience:
Medical professionals, researchers in orthopaedics
Period of Activity:
March 5-8, 2016
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Southampton, UK
Topic:
Oesophago-gastric cancer, neoadjuvant therapy, cardiopulmonary exercise testing
Document Type:
Research Article
Institution:
University of Southampton, Southampton NIHR Biomedical Research Centre
Author:
Malcolm A West, William CA Baker, Saqib Rahman, Alicia Munro, Sandy Jack, Michael PW Grocott, Timothy J Underwood, Denny ZH Levett
Target Audience:
Medical professionals, oncologists, researchers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2023
Region:
China
Subject:
Male rectal cancer, laparoscopic surgery, postoperative urogenital function
Document Type:
Clinical trial protocol
Organization:
Sun Yat-sen University, Multiple affiliated hospitals
Author:
Research Team
Target Audience:
Medical professionals, researchers, clinicians
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Singapore
Theme:
Hepatocellular carcinoma, Surgical resection
Document type:
Meta-analysis
Author:
Aaron JL Lee, Andrew GR Wu, Kuo Chao Yew, Vishal G Shelat
Target audience:
Medical professionals, Researchers
Period of validity:
Not specified
Approval date:
February 1, 2023
Date of changes:
Not specified
Year:
2024
Region / City:
N/A
Topic:
Medical protocol
Document Type:
Protocol
Organization / Institution:
CAP Laboratory Accreditation Program
Authors:
Julie C. Fanburg-Smith, MD, FCAP; Paari Murugan, MD, FCAP; Andrew Horvai, MD, PhD; Fernanda Amary, MD, PhD; Meera Hameed, MD, FCAP; Michael J. Klein, MD.
Target Audience:
Pathologists, medical professionals in oncology
Effective Period:
March 2025
Approval Date:
June 2024
Date of Changes:
June 2024
Year:
2020
Protocol Version:
4.2.0.1
Protocol Posting Date:
February 2020
Required Use Date:
February 2020
Subject:
Primary carcinoma of the vagina
Procedure:
Resection (includes vaginectomy)
Tumor Types Included:
Squamous cell carcinoma, adenocarcinoma and variants, carcinosarcoma, neuroendocrine carcinoma, mixed epithelial–neuroendocrine tumors
Staging System:
pTNM (8th Edition, AJCC Staging Manual), 2018 FIGO Cancer Report
Issuing Organization:
College of American Pathologists
Program:
CAP Laboratory Accreditation Program
Committees:
CAP Cancer Committee; CAP Pathology Electronic Reporting Committee
Authors:
Saeid Movahedi-Lankarani, MD; Uma Krishnamurti, MD, PhD; Debra A. Bell, MD; George G. Birdsong, MD; Charles V. Biscotti, MD; Christopher N. Chapman Jr, MD; Dina H. Kandil, MD; Veronica Klepeis, MD, PhD; Anthony G. Montag, MD; Christopher N. Otis, MD
Document Type:
Cancer protocol and surgical pathology reporting guideline
Applicable Specimens:
Definitive primary cancer resection specimens
Exclusions:
Biopsy specimens; cytologic specimens; lymphoma; sarcoma; recurrent or metastatic tumors resected separately
Year:
2010–2022
Region / City:
Hyogo, Japan
Subject:
Biliary Tract Cancer, Sarcopenia, Surgical Outcomes
Document Type:
Clinical Study
Institution:
Meiwa Hospital, Department of Surgery
Authors:
Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Meidai Kasai, Naoki Yamanaka
Target Audience:
Oncologists, Surgeons, Clinical Researchers
Patient Cohort:
211 patients undergoing BTC resection
Primary Tumor Sites:
Intrahepatic bile duct, Extrahepatic bile duct, Gallbladder, Ampulla of Vater
Follow-up Method:
Disease-specific survival (DSS), Relapse-free survival (RFS)
Ethics Approval:
Institutional Ethics Committee of Meiwa Hospital, approval No. 2022-36
Year:
2021
Region / City:
Australia
Topic:
Healthcare, Medicare
Document Type:
Legislative Amendment
Organization:
Australian Department of Health
Author:
Medical Services Advisory Committee (MSAC)
Target Audience:
Specialist gastroenterologists, surgical endoscopists
Effective Period:
From 1 January 2022
Approval Date:
25 November 2021
Amendment Date:
N/A
Changes Description:
Amendments to MBS item 32230 for endoscopic mucosal resection (EMR) for large colorectal polyps
Related Legislation:
Guaranteeing Medicare – changes to the Medicare Benefit Schedule
Description:
Legislative amendment to clarify time frame for EMR service following diagnostic colonoscopy for specified colorectal polyp treatments.
Year:
2021
Organisation:
International Collaboration on Cancer Reporting
Document type:
Histopathology reporting guide
Subject:
Gastrointestinal stromal tumour (GIST)
Scope:
Pathology reporting of resection specimens for GIST
Exclusions:
Metastatic GIST specimens
Edition:
1st edition
Applicable staging system:
Pathological TNM staging
Evidence framework:
NHMRC levels of evidence
Intended users:
Pathologists reporting GIST resection specimens
Related publications:
Gastrointestinal Stromal Tumour (GIST) Histopathology Reporting Guide – Biopsy Specimens; Soft Tissue Sarcoma Histopathology Reporting Guide – Resection Specimens